sabcs 2016 - sara tolaney
Published 7 years ago • 194 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
1:41
dana-farber cancer institute | sara tolaney, md, mph, at sabcs 2020
-
2:46
sara tolaney, esmo 2022: clinical trial highlights in breast cancer
-
5:13
sabcs snippets: the multinational randomized controlled preferable-effect study
-
3:36
precision medicine in breast cancer two new options from sabcs 2016
-
3:30
precision medicine in breast cancer two new options from sabcs 2016
-
20:17
sabcs snippets: after asco 2024
-
43:05
dr. puja sapra | san antonio breast cancer symposium 2022 | educational session
-
38:51
asco 2022: highlights and analysis
-
1:49
sabcs22: sara tolaney, md, mph | dana-farber cancer institute
-
4:22
sabcs snippets: destiny-breast06 phase iii trial
-
21:39
new research in metastatic breast cancer | sabcs 2019
-
20:01
dr. joseph sparano | san antonio breast cancer symposium 2022 | general session
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
5:12
new options for hr breast cancer - an update from sabcs 2016
-
13:10
dr. per karlsson | san antonio breast cancer symposium 2022 | general session
-
3:13
sara tolaney md, mph shares results from the phase 2 atempt trial at sabcs 2019